正在加载公司
Just reported
Q3 FY2027 results
From Usana Health Sciences's results release of 2026年11月3日. These are the company's first figures; its 10-Q or 10-K replaces them when filed.
Revenue
Actual
US$205.9M
-3.6% y/y
-7.8% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Usana Health Sciences is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Highest-graded in Packaged Foods
Graded A or B and worth $2B or more: A first, then the largest.
SJMJ M Smucker CoUS$14.2BA
MKCMccormick & Company, IncorporatedUS$12.7BA+
FRPTFreshpet, Inc.US$3.3BA
DARDarling Ingredients Inc.US$8.7BB+
POSTPost Holdings, Inc.US$3.6BB
Grade rose recently in Consumer Staples
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
BUDAnheuser-Busch InBev SA2026年7月30日BAGraded B, now A
MDLZMondelez International, Inc.2026年10月29日CAGraded C, now A
HSYHershey Co.2026年10月29日BAGraded B, now A
SYYSysco Corporation2026年11月4日BAGraded B, now A
ELFe.l.f. Beauty, Inc.2026年11月4日BAGraded B, now A
基于 Usana Health Sciences, Inc. 自己向美国证券交易委员会（SEC）提交的申报文件。数字如实呈报，每股历史已重述到今天的股数口径。 这是对一门生意的描述——不是投资建议，也不是买卖任何证券的推荐。
